Amelioration of experimental allergic encephalitis (EAE) through phase 2 enzyme induction

A A Mohamed1, J G Avila, E Schültke

  • 1Department of Anatomy & Cell Biology, University of Saskatchewan, Saskatoon, SK, Canada.

Biomedical Sciences Instrumentation
|June 28, 2002
PubMed

Insights

Dietary phase 2 enzyme inducers, like BHA, show promise in reducing oxidative stress and ameliorating multiple sclerosis (MS) symptoms in rats. This suggests a potential new therapeutic avenue for MS treatment.

Area of Science:

  • Neuroimmunology
  • Biochemistry
  • Toxicology

Background:

  • Multiple sclerosis (MS) involves inflammatory attacks on white matter, with oxidative stress contributing to disease progression.
  • Inducing phase 2 enzymes is a strategy to decrease oxidative stress.
  • Experimental autoimmune encephalomyelitis (EAE) in Lewis rats serves as a model for MS.

Purpose of the Study:

  • To investigate whether decreasing oxidative stress by inducing phase 2 enzymes can ameliorate MS.
  • To evaluate the effect of dietary t-butylhydroxyanisole (BHA) on EAE symptoms and oxidative stress markers.

Main Methods:

  • EAE was induced in Lewis rats, divided into control and BHA-supplemented diet groups.
  • Animals were monitored daily for clinical symptoms, and blood and tissues were collected for analysis.
  • Red blood cell glutathione (GSH) levels were measured to assess phase 2 enzyme induction.

Main Results:

  • Rats fed BHA exhibited significantly reduced clinical symptoms compared to controls.
  • BHA-fed animals showed a 20% increase in red blood cell GSH, indicating successful phase 2 enzyme induction.
  • Histological analysis revealed a correlation between reduced clinical symptoms and decreased perivascular lymphocyte infiltration.

Conclusions:

  • Dietary induction of phase 2 enzymes, demonstrated by BHA, can ameliorate EAE, a model for MS.
  • Reducing oxidative stress through dietary interventions may be a viable strategy for managing MS.
  • Further research into dietary phase 2 enzyme inducers for MS treatment is warranted.

Related Concept Videos